Ophthalmology · Arecibo, PR
NPI
1073711479
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
49b Calle Morell Campos
Arecibo, PR, 00612
Phone (787) 878-2758
Medicare paid, 2024
$9,517
164 services
Medicare patients, 2024
46
Average age 75
Drug cost, 2024
$1.7M
19,496 prescriptions
Company payments, 2025
$125
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Juan C Maldonado-Melendez was code 92012 (ophthalmological e&m), 66 times for 40 patients. In total Juan C Maldonado-Melendez billed 164 services in 14 codes, and Medicare paid $9,517.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 66 | 40 | $58.83 | $3,882 |
| 92250 Angiography | Office | 33 | 30 | $23.50 | $776 |
| 92133 Computerized Ophthalmic Imaging | Office | 15 | 15 | $24.74 | $371 |
| 92202 Ophthalmological E&M | Office | 14 | 14 | $6.81 | $95.29 |
| 92083 Vision, Hearing, and Speech Services | Office | 12 | 12 | $41.76 | $501 |
By year: 2022 $12K for 190 services; 2023 $15K for 204 services; 2024 $9,517 for 164 services.
Medicare prescription drug claims, 2024
In 2024, the drug Juan C Maldonado-Melendez prescribed most often to Medicare patients was Latanoprost, with 5,038 prescriptions and refills. In total Juan C Maldonado-Melendez wrote 19,496 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 5,038 | 5,579 | 777 | $61K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 2,593 | 4,744 | 631 | $86K |
| Lumigan Bimatoprost | 2,476 | 2,670 | 362 | $640K |
| Brimonidine Tartrate Generic | 2,052 | 2,457 | 357 | $97K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 1,055 | 1,223 | 180 | $157K |
| Prednisolone Acetate Generic | 1,003 | 1,034 | 567 | $40K |
| Dorzolamide Hcl Generic | 826 | 1,535 | 224 | $24K |
| Timolol Maleate Generic | 815 | 963 | 142 | $11K |
| Combigan Brimonidine Tartrate/Timolol | 560 | 607 | 107 | $121K |
| Ofloxacin Generic | 465 | 466 | 365 | $10K |
| Ketorolac Tromethamine Generic | 446 | 447 | 337 | $8,711 |
| Alphagan P Brimonidine Tartrate | 436 | 492 | 93 | $91K |
| Travoprost Generic | 277 | 305 | 39 | $32K |
| Vyzulta Latanoprostene Bunod | 271 | 286 | 38 | $70K |
| Simbrinza Brinzolamide/Brimonidine Tart | 264 | 355 | 45 | $56K |
Brand drugs: 7,850 claims; generic drugs: 11,646 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Juan C Maldonado-Melendez $125 ($125 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $125.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.